Apoptotic cells induce migration of phagocytes via caspase-3-mediated release of a lipid attraction signal

Cell

Volumn 113, Issue 6, 2003, Pages 717-730

  Lauber, Kirsten ^a   Bohn, Erwin ^a   Kröber, Stefan Martin ^b   Xiao, Yi Jin ^c   Blumenthal, Sibylle G ^a   Lindemann, Ralph K ^a   Marini, Patrizia ^a   Wiedig, Carolin ^a   Zobywalski, Anke ^a   Baksh, Shairaz ^d   Xu, Yan ^c   Autenrieth, Ingo B ^a   Schulze Osthoff, Klaus ^e   Belka, Claus ^a   Stuhler, Gernot ^a   Wesselborg, Sebastian ^a  

^a UNIVERSITY OF TÜBINGEN   (Germany)

^b UNIVERSITY HOSPITAL TÜBINGEN   (Germany)

^c LERNER RESEARCH INSTITUTE   (United States)

^d HARVARD MEDICAL SCHOOL   (United States)

^e HEINRICH HEINE UNIVERSITY   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

CALCIUM; CASPASE 3; CHEMOTACTIC FACTOR; LYSOPHOSPHATIDYLCHOLINE; PHOSPHOLIPASE A2; PHOSPHOLIPID;

ANIMAL CELL; APOPTOSIS; ARTICLE; CELL FUNCTION; CONTROLLED STUDY; ENZYME ACTIVATION; HUMAN; HUMAN CELL; MACROPHAGE MIGRATION; MEDIATOR RELEASE; MOUSE; NONHUMAN; PHAGOCYTE; PRIORITY JOURNAL; SIGNAL TRANSDUCTION;

ANIMALIA;

EID: 0038820117     PISSN: 00928674     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0092-8674(03)00422-7     Document Type: Article

References (34)

1. 2s in fatty acid release in the cell death pathway. J. Biol. Chem. 275:2000;18248-18258.
2. 2 to liberate arachidonic acid. Biochim. Biophys. Acta. 1349:1997;43-54.
3. 2, which undergoes proteolytic inactivation. J. Biol. Chem. 273:1998;13870-13877.
4. 2 enzymes present in P388D1 macrophages. J. Biol. Chem. 271:1996;6758-6765.
5. + cells in vivo J. Immunol. 165:2000;6029-6035.
6. Brown S., Heinisch I., Ross E., Shaw K., Buckley C.D., Savill J. Apoptosis disables CD31-mediated cell detachment from phagocytes promoting binding and engulfment. Nature. 418:2002;200-203.
7. Engels I.H., Stepczynska A., Stroh C., Lauber K., Berg C., Schwenzer R., Wajant H., Jänicke R.U., Porter A.G., Belka C.et al. Caspase-8/FLICE functions as an executioner caspase in anticancer drug-induced apoptosis. Oncogene. 19:2000;4563-4573.
8. Fadok V.A., Bratton D.L., Konowal A., Freed P.W., Westcott J.Y., Henson P.M. Macrophages that have ingested apoptotic cells in vitro inhibit proinflammatory cytokine production through autocrine/paracrine mechanisms involving TGF-beta, PGE2, and PAF. J. Clin. Invest. 101:1998;890-898.
9. Fadok V.A., Bratton D.L., Rose D.M., Pearson A., Ezekewitz R.A., Henson P.M. A receptor for phosphatidylserine-specific clearance of apoptotic cells. Nature. 405:2000;85-90.
10. 2 generates the novel lipid mediator lysophosphatidic acid in membrane microvesicles shed from activated cells. Cell. 80:1995;919-927.
11. Galluci S., Lolkema M., Matzinger P. Natural adjuvants. endogenous activators of dendritic cells Nat. Med. 5:1999;1249-1255.
12. Gumienny T.L., Brugnera E., Tosello-Trampont A.C., Kinchen J.M., Haney L.B., Nishiwaki K., Walk S.F., Nemergut M.E., Macara I.G., Francis R.et al. CED-12/ELMO, a novel member of the CrkII/Dock180/Rac pathway, is required for phagocytosis and cell migration. Cell. 107:2001;27-41.
13. Hengartner M.O. Apoptosis. corralling the corpses Cell. 104:2001;325-328.
14. Hoffman R.D., Kligerman M., Sundt T.M., Anderson N.D., Shin H.S. Stereospecific chemoattraction of lymphoblastic cells by gradients of lysophosphatidylcholine. Proc. Natl. Acad. Sci. USA. 79:1982;3285-3289.
15. Honda S., Sasaki Y., Ohsawa K., Imai Y., Nakamura Y., Inoue K., Kohsaka S. Extracellular ATP or ADP induce chemotaxis of cultured microglia through Gi/o-coupled P2Y receptors. J. Neurosci. 21:2001;1975-1982.
16. Jänicke R.U., Sprengart M.L., Wati M.R., Porter A.G. Caspase-3 is required for DNA fragmentation and morphological changes associated with apoptosis. J. Biol. Chem. 273:1998;9357-9360.
17. Kabarowski J.H.S., Zhu K., Le L.Q., Witte O.N., Xu Y. Lysophosphatidylcholine as a ligand for the immunoregulatory receptor G2A. Science. 293:2001;702-705.
18. 2 activation during apoptosis promotes the exposure of membrane lysophosphatidylcholine leading to binding by natural immunoglobulin M antibodies and complement activation. J. Exp. Med. 196:2002;655-665.
19. 2 and their effect on enzyme activity. J. Biol. Chem. 273:1998;207-214.
20. Lauber K., Appel H.A., Schlosser S.F., Gregor M., Schulze Osthoff K., Wesselborg S. The adapter protein apoptotic protease-activating factor-1 (Apaf-1) is proteolytically processed during apoptosis. J. Biol. Chem. 276:2001;29772-29781.
21. Le Q.L., Kabarowski J.H.S., Weng Z., Satterthwaite A.B., Harvill E.T., Jensen E.R., Miller J.F., Witte O.N. Mice lacking the orphan G protein-coupled receptor G2A develop a late-onset autoimmune syndrome. Immunity. 14:2001;561-571.
22. 2s. Biochim. Biophys. Acta. 1488:2000;159-166.
23. Reddien P.W., Horvitz H.R. CED-2/CrkII and CED-10/Rac control phagocytosis and cell migration in Caenorhabditis elegans. Nat. Cell Biol. 2:2000;131-136.
24. Rosen A., Casciola-Rosen L. Autoantigens as substrates for apoptotic proteases. implications for the pathogenesis of systemic autoimmune disease Cell Death Differ. 6:1999;6-12.
25. Rudel T., Bokoch G.M. Membrane and morphological changes in apoptotic cells regulated by caspase-mediated activation of PAK2. Science. 276:1997;1571-1574.
26. Sauter B., Albert M.L., Francisco L., Larsson M., Somersan S., Bhardwaj N. Consequences of cell death. exposure to necrotic tumor cells, but not primary tissue cells or apoptotic cells, induces the maturation of immunostimulatory dendritic cells J. Exp. Med. 191:2000;423-434.
27. Savill J., Fadok V. Corpse clearance defines the meaning of cell death. Nature. 407:2000;784-788.
28. Sebbagh M., Renvoize C., Hamelin J., Riche N., Bertoglio J., Breard J. Caspase-3-mediated cleavage of ROCK I induces MLC phosphorylation and apoptotic membrane blebbing. Nat. Cell Biol. 3:2001;346-352.
29. Segundo C., Medina F., Rodriguez C., Martinez-Palencia R., Leyva-Cobian F., Brieva J.A. Surface molecule loss and bleb formation by human germinal center B cells undergoing apoptosis. role of apoptotic blebs in monocyte chemotaxis Blood. 94:1999;1012-1020.
30. 2. Biochemistry. 32:1993;5935-5940.
31. Xiao Y., Chen Y., Kennedy A.W., Belinson J., Xu Y. Evaluation of plasma lysophospholipids for diagnostic significance using electrospray ionization mass spectrometry (ESI-MS) analyses. Ann. N Y Acad. Sci. 905:2000;242-259.
32. Xiao Y.J., Schwartz B., Washington M., Kennedy A., Webster K., Belinson J., Xu Y. Electrospray ionization mass spectrometry analysis of lysophospholipids in human ascitic fluids. comparison of the lysophospholipid contents in malignant vs nonmalignant ascitic fluids Anal. Biochem. 290:2001;302-313.
33. Xu Y., Zhu K., Hong G., Wu W., Baudhuin L.M., Xiao Y.-I., Damron D.S. Sphingosylphosphorylcholine is a ligand for ovarian cancer G-protein-coupled receptor 1. Nat. Cell Biol. 2:2000;261-267.
34. Zhu K., Baudhuin L.M., Hong G., Williams F.S., Cristina K.L., Kabarowski J.H., Witte O.N., Xu Y. Sphingosylphosphorylcholine and lysophosphatidylcholine are ligands for the G protein-coupled receptor GPR4. J. Biol. Chem. 276:2001;41325-41335.